Skip to main content
FinSpry Logo
FinSpry
CYTK logo
CYTK
(NASDAQ)
Cytokinetics, Incorporated
$81.92-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cytokinetics, Incorporated (CYTK) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Cytokinetics, Incorporated stock.

Analyst Consensus Rating

Investment consensus from 15 professional research analysts

Consensus Rating

Buy
Based on 15 unique analysts
(24 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$107.21
↑ 30.87% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CYTK Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Leonid Timashev
RBC Capital
BuyMaintains
$119.00 → $117.00
Ashwani Verma
UBS
BuyUpgrades
$115.00
Serge Belanger
Needham
BuyMaintains
$102.00
Salim Syed
Mizuho
BuyMaintains
$100.00 → $118.00
Jason Zemansky
BofA Securities
HoldMaintains
$67.00 → $83.00
Eric Joseph
Citi
BuyReiterates
$99.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$103.00
Jason Zemansky
BofA Securities
HoldMaintains
$67.00 → $83.00
Eric Joseph
Citi
BuyReiterates
$99.00
Serge Belanger
Needham
BuyMaintains
$102.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$103.00
Tessa Romero
JP Morgan
BuyMaintains
$97.00
Eric Joseph
Citi
BuyInitiates
$99.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$103.00
Joseph Pantginis
HC Wainwright
BuyReiterates
$140.00
Joseph Pantginis
HC Wainwright
BuyReiterates
$140.00
James Condulis
Stifel Nicolaus
BuyReiterates
$98.00 → $108.00
Yanan Zhu
Wells Fargo
BuyMaintains
$95.00 → $105.00
Unknown Analyst
Raymond James
HoldMaintains
-
James Condulis
Stifel Nicolaus
BuyInitiates Coverage
$98.00 → $108.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$107.00
Srikripa Devarakonda
Truist
BuyReiterates
$92.00 → $106.00
Paul Choi
Goldman Sachs
BuyReiterates
$101.00
Leonid Timashev
RBC Capital
BuyMaintains
$101.00 → $119.00

Frequently Asked Questions

What is the analyst consensus rating for CYTK?

The analyst consensus rating for CYTK is "Buy" based on 15 analyst recommendations.

What is the average price target for CYTK?

The average 12-month price target for CYTK is $107.21, representing an upside of 30.9% from the current price of $81.92.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.